Fulgent Therapeutics LLC

El Monte, CA Doing business as Fulgent Diagnostics Fulgent Therapeutics LLC Part of Fulgent Genetics, Inc.

UEI
JVZDRESJLD82
CAGE
7BRL2
Primary NAICS
621511 Medical Laboratories
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Limited Liability Company
Entity structure
Partnership or Limited Liability Partnership
NAICS codes registered in SAM.gov
Corporate family
SAM.gov registration date
Physical address
4399 Santa Anita Ave, El Monte, CA 91731, USA
Website
fulgentgenetics.com
Founded
2011
Employees
251-1K
Estimated annual revenue
$50M-$100M
Industry
  1. Industrials
  2. Commercial & Professional Services
  3. Professional Services
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Fulgent Therapeutics LLC's 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Germline PGX molecular testing Contract · 36C10X26N0165 VA Strategic Acquisition Center Frederick $6,574
IDIQ, germline genetic testing services for veterans health adminstration national onocology program (NOP), year 2 Contract · 36C10X25N0265 VA Strategic Acquisition Center Frederick $6,573,600
Genetics testing Contract · 36C25625C0001 Veterans Integrated Service Network 16 $383,754
Germline PGX molecular testing Contract · 36C10X24N0227 VA Strategic Acquisition Center Frederick $2,949,000
Clinical genetic testing (CKD) Contract · 36C24823P0565 Veterans Integrated Service Network 8 $201,500

About Fulgent Therapeutics LLC

Written by GovTribe AI ·

Fulgent Therapeutics LLC, doing business as Fulgent Diagnostics, is a for-profit limited liability company based in El Monte, California, and a subsidiary of Fulgent Genetics, Inc. The company specializes in advanced genetic testing, genomic sequencing, and diagnostic services for federal agencies. As a registered federal contractor, Fulgent Therapeutics provides comprehensive genetic and molecular testing solutions across multiple medical specialties, with a strong focus on serving government healthcare institutions.

The company has secured multiple federal contract awards primarily from the Department of Veterans Affairs, Department of Health and Human Services, Centers for Disease Control and Prevention, and Department of the Army. These contracts encompass a wide range of genetic testing services, including clinical genetic testing for conditions like chronic kidney disease, germline genetic testing for oncology programs, anatomic pathology laboratory services, and specialized molecular testing. Notably, all of Fulgent Therapeutics' federal contract awards have been issued without specific set-aside designations, indicating open competition. The contract values range from small purchase orders around $7,251 to significant awards like a $40,517,395 contract for SARS-COV-2 genomic sequencing with the CDC, demonstrating the company's versatility in genetic testing and diagnostic services.

Fulgent Therapeutics holds two significant federal contract Indefinite Delivery Vehicles (IDVs): a $500,000 Blanket Purchase Agreement with the Department of the Army Medical Command for genetic testing at Tripler Army Medical Center, and a $99,032,828.20 multiple-award Indefinite Delivery Contract with the VA Strategic Acquisition Center. The VA contract provides national access to germline genetic testing across oncology, medical genetics, and pharmacogenomics, with task orders already being issued. These IDVs enable the company to provide standardized, advanced genetic diagnostic technologies to federal healthcare facilities, with capabilities including next-generation sequencing, consultation, and result interpretation across multiple medical specialties. The IDVs have performance periods extending through 2029-2030, indicating a long-term strategic partnership with federal healthcare agencies.

Contract vehicles

Fulgent Therapeutics LLC holds a place on 2 federal contract vehicles. Active vehicles first.

Quick answers

What is Fulgent Therapeutics LLC's UEI?

Fulgent Therapeutics LLC's Unique Entity ID (UEI) in SAM.gov is JVZDRESJLD82.

What is Fulgent Therapeutics LLC's CAGE code?

Fulgent Therapeutics LLC's CAGE code is 7BRL2.

What is Fulgent Therapeutics LLC's primary NAICS code?

Fulgent Therapeutics LLC's primary NAICS code is 621511 (Medical Laboratories).

Where is Fulgent Therapeutics LLC located?

Fulgent Therapeutics LLC's physical address in SAM.gov is 4399 Santa Anita Ave, El Monte, CA 91731, USA.

Is Fulgent Therapeutics LLC registered in SAM.gov?

Fulgent Therapeutics LLC's SAM.gov registration expired on June 18, 2026.

Who is Fulgent Therapeutics LLC's parent company?

Fulgent Therapeutics LLC is part of Fulgent Genetics, Inc.

Which contract vehicles does Fulgent Therapeutics LLC hold?

Fulgent Therapeutics LLC holds a place on 2 federal contract vehicles, including Germline PGx Services.

What is Fulgent Therapeutics LLC's most recent federal award?

Fulgent Therapeutics LLC's most recent federal contract award is Germline PGX molecular testing (36C10X26N0165), from VA Strategic Acquisition Center Frederick, on September 30, 2026.

On GovTribe

See Fulgent Therapeutics LLC's full federal record

  • Federal contract awards
  • IDV awards
  • Contract vehicles
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login